Novo Nordisk Foundation Cellerator Email Formats
Biotechnology Research • 
Nordvej 250a, Lyngby, Denmark • 11-20 Employees
Novo Nordisk Foundation Cellerator Email Formats
Novo Nordisk Foundation Cellerator uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
Key Contacts at Novo Nordisk Foundation Cellerator
Thomas H. R. Carlsen
Ceo Of Novo Nordisk Foundation Cellerator
Søren Hanghøj
Project Director
Company overview
| Headquarters | Nordvej 250a, Lyngby, Capital Region of Denmark 2800, DK |
| Website | |
| NAICS | 541714 |
| Employees | 11-20 |
About Novo Nordisk Foundation Cellerator
The Novo Nordisk Foundation Cellerator is built on the belief that cell therapy holds the key to curing chronic or life-threatening diseases. Despite significant research progress, many promising therapies never reach patients. That is why we are creating the Cellerator, a state-of-the-art hub dedicated to advancing the cell therapy ecosystem by accelerating the development and manufacturing of cell therapies for early clinical trials. Our facility at the Technical University of Denmark (DTU) will support multiple cell types and provide essential services such as process development, GMP manufacturing and release, and regulatory support. Built to close the gap from technology to treatment, Cellerator shortens the journey from groundbreaking concepts to clinical trials. We achieve this by fostering partnerships among startups, pharmaceutical companies, and research institutions, leveraging our expertise, network, and infrastructure to develop and commercialize new cell therapies more effectively. Cellerator, expected to be operational by 2027, is a philanthropic initiative that serves public and private clients globally, to further advance the field. We believe in the future of regenerative medicine and are dedicated to accelerating transformative treatments for a healthier tomorrow. Follow us and visit our website to learn more and sign up for the interest list.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Novo Nordisk Foundation Cellerator has 10 employees across 6 departments.
Departments
Number of employees
Funding Data
Novo Nordisk Foundation Cellerator has never raised funding before.
Novo Nordisk Foundation Cellerator Tech Stack
Discover the technologies and tools that power Novo Nordisk Foundation Cellerator's digital infrastructure, from frameworks to analytics platforms.
CDN
Cookie compliance
JavaScript frameworks
Tag managers
Security
Miscellaneous
JavaScript frameworks
CMS
JavaScript libraries
Miscellaneous
CDN
Performance
Netherlands
South Africa
United States
United Kingdom
Frequently asked questions
4.8
40,000 users
